Global Cardiopulmonary Autotransfusion Systems Market 2016-2020

Global Cardiopulmonary Autotransfusion Systems Market 2016-2020

Category : Medical Devices
Sub Category : General Medical Device
Published On : June  2016
Pages : 65



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About the Cardiopulmonary Autotransfusion Systems Market
 
Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac operations. This procedure is processed in autotransfusion systems that help minimize blood loss by collecting and filtering the RBCs, and reinfusing the blood into an individual.
 
Autotransfusion is an autologous technology involving the retransfusion of a person's own blood, which increases the ineed for traditional centrifuge devices for separating the RBCs from the blood. Advances in technology have led companies to integrate ultrafiltration technique for blood collection. For instance, Advancis Surgical's ultrafiltration-based HemoSep system can improve patient recovery time by filtering inflammatory molecules, preserving normal clotting function, and maintaining platelet populations.
 
Technavio’s analysts forecast the global cardiopulmonary autotransfusion systems to grow at a CAGR of 1.91% during the period 2016-2020.
 
Covered in this report 
The report covers the present scenario and the growth prospects of the global cardiopulmonary autotransfusion systems for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the total consumption of cardiopulmonary autotransfusion systems globally. These systems help reduce the risk of infections that can occur due to the use of allogenic blood.
 
The market is divided into the following segments based on geography: 
• Americas
• APAC
• EMEA 
Technavio's report, Global Cardiopulmonary Autotransfusion Systems Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market. 
 
Key vendors 
• Advancis Surgical
• Fresenius Kabi
• Haemonetics
• LivaNova
• Medtronic
• Terumo 

Other prominent vendors
• Atrium Medical
• Global Blood Resources
• Redax
• Sarstedt
• Stryker 

Market driver 
• Rise in cardiac surgeries
• For a full, detailed list, view our report 
 
Market challenge 
• Limitations of autotransfusion technology
• For a full, detailed list, view our report 
 
Market trend 
• Development of ultrafiltration systems
• For a full, detailed list, view our report 
 
Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors? 
 
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Cardiopulmonary diseases: An overview
• Cardiopulmonary autotransfusion systems: An overview
• Role of autotransfusion in cardiac surgeries
• Cardiopulmonary autotransfusion process

PART 05: Classification of medical devices
• Classification of medical devices

PART 06: Cost analysis
• Cost analysis of cardiopulmonary autotransfusion systems

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by end-user
• Hospitals
• ASCs

PART 09: Geographical segmentation
• Cardiopulmonary autotransfusion systems market in Americas
• Cardiopulmonary autotransfusion systems market in EMEA
• Cardiopulmonary autotransfusion systems market in APAC

PART 10: Market drivers
• Rise in cardiac surgeries
• Complications of allogenic blood transfusion
• Advances in autotransfusion technology

PART 11: Impact of drivers

PART 12: Market challenges
• Limitations of autotransfusion technology
• Use of allogenic blood transfusion
• Stringent regulatory framework and medical policies

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Development of ultrafiltration systems
• Significant opportunities in emerging countries
• Public awareness

PART 15: Vendor landscape
• Competitive scenario

PART 16: Major vendors
• Advancis Surgical
• Fresenius Kabi
• Haemonetics
• LivaNova
• Medtronic
• Terumo
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Types of cardiopulmonary diseases
Exhibit 03: Peri-operative period and its different stages
Exhibit 04: History of autotransfusion
Exhibit 05: Autotransfusion systems for other surgeries
Exhibit 06: Process of autotransfusion
Exhibit 07: Components of cardiopulmonary autotransfusion system
Exhibit 08: Cost analysis of cardiopulmonary autotransfusion
Exhibit 09: Cost breakdown of CABG surgery and cardiopulmonary autotransfusion 2015
Exhibit 10: Global cardiopulmonary autotransfusion systems market 2015-2020 ($ millions)
Exhibit 11: Five forces analysis
Exhibit 12: Global cardiopulmonary autotransfusion systems market segmentation by end-user 2015
Exhibit 13: Global cardiopulmonary autotransfusion systems market segmentation by geography 2015
Exhibit 14: Global cardiopulmonary autotransfusion systems market segmentation by geography 2020
Exhibit 15: Global cardiopulmonary autotransfusion systems market segmentation by geography 2015-2020
Exhibit 16: Global cardiopulmonary autotransfusion systems market segmentation by geography 2015-2020 ($ millions)
Exhibit 17: Cardiopulmonary autotransfusion systems market in Americas 2015-2020 ($ millions)
Exhibit 18: Comparison of US healthcare system: Before and after reforms
Exhibit 19: Implements amended in ACA
Exhibit 20: Number of coronary bypass surgeries per 100,000 people in Europe 2013
Exhibit 21: Cardiopulmonary autotransfusion systems market in EMEA 2015-2020 ($ millions)
Exhibit 22: Cardiopulmonary autotransfusion systems market in APAC 2015-2020 ($ millions)
Exhibit 23: Impact of drivers
Exhibit 24: Impact of drivers and challenges
Exhibit 25: Advancis Surgical: Key takeaways
Exhibit 26: Fresenius Kabi: Key products
Exhibit 27: Fresenius Kabi: Key takeaways
Exhibit 28: Haemonetics: Product segmentation by revenue FY2016
Exhibit 29: Haemonetics: Product segmentation by revenue 2015 and FY2016 ($ millions)
Exhibit 30: Haemonetics: Key takeaways
Exhibit 31: LivaNova: Key products
Exhibit 32: LivaNova: Revenue of cardiac surgery segment by geographical segmentation 2015
Exhibit 33: LivaNova: Key takeaways
Exhibit 34: Medtronic: Key product
Exhibit 35: Medtronic: Key takeaways
Exhibit 36: Terumo: Key product
Exhibit 37: Terumo: Key takeaways

Enquiry Before Buy
image
Can´t read the image ? refresh here.